http://biomedme.com Medical Equipments for Middle East Thu, 09 Sep 2010 13:31:35 +0000 en hourly 1 http://wordpress.org/?v=3.0 http://biomedme.com/featured/switching-from-protease-inhibitors-to-nevirapine-brings-superior-results-for-some-hiv-infected-children_11597.html http://biomedme.com/featured/switching-from-protease-inhibitors-to-nevirapine-brings-superior-results-for-some-hiv-infected-children_11597.html#comments Thu, 09 Sep 2010 07:15:17 +0000 imran http://biomedme.com/?p=11597 http://biomedme.com/featured/switching-from-protease-inhibitors-to-nevirapine-brings-superior-results-for-some-hiv-infected-children_11597.html/feed 0 http://biomedme.com/featured/hemispherx-biopharma-to-present-clinical-data-on-xmrv-retrovirus-at-international-workshop_11586.html http://biomedme.com/featured/hemispherx-biopharma-to-present-clinical-data-on-xmrv-retrovirus-at-international-workshop_11586.html#comments Thu, 09 Sep 2010 06:46:05 +0000 imran http://biomedme.com/?p=11586 http://biomedme.com/featured/hemispherx-biopharma-to-present-clinical-data-on-xmrv-retrovirus-at-international-workshop_11586.html/feed 0 http://biomedme.com/pharmaceuticals/map-pharmaceuticals-completes-12-months-of-treatment-in-levadex-open-label-safety-trial_11530.html http://biomedme.com/pharmaceuticals/map-pharmaceuticals-completes-12-months-of-treatment-in-levadex-open-label-safety-trial_11530.html#comments Wed, 08 Sep 2010 15:42:19 +0000 imran http://biomedme.com/?p=11530 http://biomedme.com/pharmaceuticals/map-pharmaceuticals-completes-12-months-of-treatment-in-levadex-open-label-safety-trial_11530.html/feed 0 http://biomedme.com/pharmaceuticals/progenics-commences-phase-3-trial-of-oral-methylnaltrexone-for-opioid-induced-constipation_11528.html http://biomedme.com/pharmaceuticals/progenics-commences-phase-3-trial-of-oral-methylnaltrexone-for-opioid-induced-constipation_11528.html#comments Wed, 08 Sep 2010 15:39:27 +0000 imran http://biomedme.com/?p=11528 http://biomedme.com/pharmaceuticals/progenics-commences-phase-3-trial-of-oral-methylnaltrexone-for-opioid-induced-constipation_11528.html/feed 0 http://biomedme.com/health-care/bmj-investigation-raises-concern-on-rosiglitazone-diabetes-drug-safety_11487.html http://biomedme.com/health-care/bmj-investigation-raises-concern-on-rosiglitazone-diabetes-drug-safety_11487.html#comments Wed, 08 Sep 2010 07:08:46 +0000 imran http://biomedme.com/?p=11487 http://biomedme.com/health-care/bmj-investigation-raises-concern-on-rosiglitazone-diabetes-drug-safety_11487.html/feed 0 http://biomedme.com/health-care/fluctuation-in-pcv-7-vaccine-dosing-time-increases-pneumococcal-serotype-19a-strains_11480.html http://biomedme.com/health-care/fluctuation-in-pcv-7-vaccine-dosing-time-increases-pneumococcal-serotype-19a-strains_11480.html#comments Wed, 08 Sep 2010 06:54:52 +0000 imran http://biomedme.com/?p=11480 http://biomedme.com/health-care/fluctuation-in-pcv-7-vaccine-dosing-time-increases-pneumococcal-serotype-19a-strains_11480.html/feed 0 http://biomedme.com/health-care/forest-laboratories-ceftaroline-fosamil-receives-fda-advisory-committee-approval-for-cabp-and-csssi_11478.html http://biomedme.com/health-care/forest-laboratories-ceftaroline-fosamil-receives-fda-advisory-committee-approval-for-cabp-and-csssi_11478.html#comments Wed, 08 Sep 2010 06:49:08 +0000 imran http://biomedme.com/?p=11478 http://biomedme.com/health-care/forest-laboratories-ceftaroline-fosamil-receives-fda-advisory-committee-approval-for-cabp-and-csssi_11478.html/feed 0 http://biomedme.com/health-care/vertex-hepatitis-c-drug-helps-the-hard-to-treat_11464.html http://biomedme.com/health-care/vertex-hepatitis-c-drug-helps-the-hard-to-treat_11464.html#comments Wed, 08 Sep 2010 00:28:19 +0000 imran http://biomedme.com/?p=11464 http://biomedme.com/health-care/vertex-hepatitis-c-drug-helps-the-hard-to-treat_11464.html/feed 0 http://biomedme.com/health-care/key-to-slowing-rise-of-antibiotic-resistant-infections-is-pharmaceutical-conservation_11445.html http://biomedme.com/health-care/key-to-slowing-rise-of-antibiotic-resistant-infections-is-pharmaceutical-conservation_11445.html#comments Tue, 07 Sep 2010 13:03:51 +0000 imran http://biomedme.com/?p=11445 http://biomedme.com/health-care/key-to-slowing-rise-of-antibiotic-resistant-infections-is-pharmaceutical-conservation_11445.html/feed 0 http://biomedme.com/featured/levitra-10mg-orodispersible-tablet-for-the-treatment-of-erectile-dysfunction-approved-in-europe_11398.html http://biomedme.com/featured/levitra-10mg-orodispersible-tablet-for-the-treatment-of-erectile-dysfunction-approved-in-europe_11398.html#comments Tue, 07 Sep 2010 07:31:25 +0000 imran http://biomedme.com/?p=11398 http://biomedme.com/featured/levitra-10mg-orodispersible-tablet-for-the-treatment-of-erectile-dysfunction-approved-in-europe_11398.html/feed 0 http://biomedme.com/health-care/novartis-and-collaborators-discover-novel-antimalarial-drug-candidate_11379.html http://biomedme.com/health-care/novartis-and-collaborators-discover-novel-antimalarial-drug-candidate_11379.html#comments Tue, 07 Sep 2010 07:17:02 +0000 imran http://biomedme.com/?p=11379 http://biomedme.com/health-care/novartis-and-collaborators-discover-novel-antimalarial-drug-candidate_11379.html/feed 0 http://biomedme.com/health-care/single-dose-of-experimental-malaria-drug-clears-parasites-in-mice-represents-potential-new-class-of-drugs-to-treat-malaria-in-humans_11322.html http://biomedme.com/health-care/single-dose-of-experimental-malaria-drug-clears-parasites-in-mice-represents-potential-new-class-of-drugs-to-treat-malaria-in-humans_11322.html#comments Mon, 06 Sep 2010 09:37:39 +0000 imran http://biomedme.com/?p=11322 http://biomedme.com/health-care/single-dose-of-experimental-malaria-drug-clears-parasites-in-mice-represents-potential-new-class-of-drugs-to-treat-malaria-in-humans_11322.html/feed 0 http://biomedme.com/health-care/microplasmin-mivi-trust-phase-iii-programs-positive-pooled-results-presented-at-euretina_11313.html http://biomedme.com/health-care/microplasmin-mivi-trust-phase-iii-programs-positive-pooled-results-presented-at-euretina_11313.html#comments Mon, 06 Sep 2010 08:53:28 +0000 imran http://biomedme.com/?p=11313 http://biomedme.com/health-care/microplasmin-mivi-trust-phase-iii-programs-positive-pooled-results-presented-at-euretina_11313.html/feed 0 http://biomedme.com/featured/diabetes-drug-available-on-nhs-months-after-experts-call-for-withdrawal_11277.html http://biomedme.com/featured/diabetes-drug-available-on-nhs-months-after-experts-call-for-withdrawal_11277.html#comments Mon, 06 Sep 2010 00:20:34 +0000 imran http://biomedme.com/?p=11277 http://biomedme.com/featured/diabetes-drug-available-on-nhs-months-after-experts-call-for-withdrawal_11277.html/feed 0 http://biomedme.com/pharmaceuticals/tibotec-pharmaceuticals-seeks-european-marketing-authorization-for-investigational-once-daily-hiv-treatment-tmc278_11255.html http://biomedme.com/pharmaceuticals/tibotec-pharmaceuticals-seeks-european-marketing-authorization-for-investigational-once-daily-hiv-treatment-tmc278_11255.html#comments Sun, 05 Sep 2010 09:26:43 +0000 imran http://biomedme.com/?p=11255 http://biomedme.com/pharmaceuticals/tibotec-pharmaceuticals-seeks-european-marketing-authorization-for-investigational-once-daily-hiv-treatment-tmc278_11255.html/feed 0